SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-11-038580
Filing Date
2011-07-29
Accepted
2011-07-29 17:06:18
Documents
13
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 PDL BIOPHARMA, INC. 10-Q 6-30-3011 form10-q.htm 10-Q 1185849
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 568996
3 EXHIBIT 10.3 ex10_3.htm EX-10.3 38977
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 11273
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 11318
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 7758
13 logo.jpg GRAPHIC 9123
  Complete submission text file 0001140361-11-038580.txt   7587561

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pdli-20110630.xml EX-101.INS 1162836
8 XBRL TAXONOMY EXTENSION SCHEMA pdli-20110630.xsd EX-101.SCH 41664
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdli-20110630_cal.xml EX-101.CAL 64929
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdli-20110630_def.xml EX-101.DEF 80534
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdli-20110630_lab.xml EX-101.LAB 435680
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdli-20110630_pre.xml EX-101.PRE 254861
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 11998171
SIC: 2836 Biological Products, (No Diagnostic Substances)